Registration Dossier
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 217-168-8 | CAS number: 1761-71-3
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Eye irritation
Administrative data
- Endpoint:
- eye irritation, other
- Remarks:
- This is in vivo study but correct assignment results in validation failure.
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: Similar to a guideline study, but the dose was lower, exposure times shorter and washing procedures different than OECD guidelines.
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 985
- Report date:
- 1111
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- other: Haskell Laboratories protocol, E.I. DuPont DeNemours and Company, Wilmington, DE, USA
- Principles of method if other than guideline:
- Test material is administered into the conjunctival sac of a New Zealand white rabbit, and after various times, the material is removed by washing with various mixtures. Irritation is observed
- GLP compliance:
- not specified
Test material
- Reference substance name:
- 4,4'-methylenebis(cyclohexylamine)
- EC Number:
- 217-168-8
- EC Name:
- 4,4'-methylenebis(cyclohexylamine)
- Cas Number:
- 1761-71-3
- Molecular formula:
- C13H26N2
- IUPAC Name:
- 4,4'-methylenedicyclohexanamine
- Details on test material:
4,4'-Methylenedicyclohexanamine > 95% purity. Liquid with freezing/melting point of 13 degrees C.
Isomer content (%):
trans-trans 21.22
cis-cis 14.91
cis-trans 59.67
Impurities:2,4'-Methylenedicyclohexanamine: 4.20%
[4-(p-aminobenzyl)cyclohexylamine] methane (PABC): 0.23%
p-aminodicyclohexylmethane (ADCM): 0.05%
p-PABC: 0.038%
Constituent 1
Test animals / tissue source
- Species:
- rabbit
- Strain:
- New Zealand White
- Details on test animals or tissues and environmental conditions:
- males, each weighing 2-3 kg.
Test system
- Vehicle:
- unchanged (no vehicle)
- Controls:
- not required
- Amount / concentration applied:
- 0.01 ml. The standard dose of 0.1% ml resulted in clear eye corrosion.
- Observation period (in vivo):
- 60 days
- Number of animals or in vitro replicates:
- 3 per group
- Details on study design:
- Test material(0.01ml) was placed in the conjunctival sac and washed with tap water for one minute with tap water after 20 seconds or two minutes. The untreated eye served as the control. Observations of cornea, iris and conjunctiva were made with a hand-slit lamp at 1 and 4 hours after administration, at 1,2 and 3 days, and weekly through 60 days after administration. Fluor-i-strip (R) ophthalmic indicators and a biomicroscope were used at examinations 1 and 4 hours after administration. A veterinary ophthalmologist was consulted for selected case examinations. Three animals were sacrificed on day 70 after treatment for histopathologic examination. Eyes were excised, washed, fixed and hardened according to the method of Saunders and Rubin (1975).
Results and discussion
In vivo
Results
- Irritation parameter:
- other: qualitative assessment
- Basis:
- mean
- Time point:
- other: 60 days
- Reversibility:
- other: 30% reversible within 60 days.
- Remarks on result:
- other: Dose of 0.01 ml is 1/10th "standard" dose of 0.1 ml.
- Irritant / corrosive response data:
- Pupillary constriction at 1-4 h, pupillary dilation through day 7, iridial congestion, with injection at 28 days, clouds of precipitate in anterior chamber, diffuse fibrous opacities of the lens, swelling and endothelial relucency by 7 days, corneal vascularization by 14 days, with subsequent healing of the ulceration by 35 days. The conjunctiva showed extreme redness and swelling within 1 h, with moderate to severe discharge (sometimes bloody and purulent).
- Other effects:
- Histopathology revealed dense corneal scarring, inflammation and lenticular opacity in selected animals. Vascular scarring of cornea can occur. In severe cases, crystals form and clots, with protein and cells present in the anterior chamber, and the lens capsule can rupture.
Any other information on results incl. tables
Each group of 3 rabbits had one rabbit whose eye was normal or nearly normal at 60 days after treatment. One other rabbit had partial healing (partial pannus), and the final rabbit had severe permanent ocular damage. Several rabbits’ eyes developed corneal opacities, still present at 60 days. Histopathology revealed some damage not observed upon gross examination.
Applicant's summary and conclusion
- Interpretation of results:
- Category 1 (irreversible effects on the eye)
- Remarks:
- Migrated information corrosive when 0.1 ml is applied in vivo; partially reversible when 0.01 ml is applied and washed in vivo. Criteria used for interpretation of results: EU
- Conclusions:
- 4,4'-Methylenedicyclohexanamine causes severe damage to the eye.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.

Route: .live1